Sertraline

FDA Drug Profile — Sertraline, Sertraline HCl, SERTRALINE

Sertraline is listed in the FDA National Drug Code directory with 42 NDC codes, marketed under brand names including Sertraline, Sertraline HCl, SERTRALINE. Available dosage forms: powder, tablet, film coated, capsule.

Drug details

Generic Name
Sertraline
Brand Names
Sertraline, Sertraline HCl, SERTRALINE
Application Number
ANDA076465
Sponsor
Viatris Pharmaceuticals LLC
NDC Codes
42
Dosage Forms
POWDER, TABLET, FILM COATED, CAPSULE
Routes
ORAL
Active Ingredients
SERTRALINE, SERTRALINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Sertraline hydrochloride tablets are indicated for the treatment of the following [ See Clinical Studies ( 14 ) ]: • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of ( 1 ): • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.